Alembic Pharmaceuticals Ltd

NSE: APLLTD · BSE: 533573 · Pharmaceuticals & Biotechnology · 65 announcements

Share price: ₹833.80
Market cap: ₹16,389 Cr
Revenue (annual): ₹7,345 Cr
Net profit (annual): ₹674.8 Cr
P/E (TTM): 23.6×Sector 47.3×
Promoter holding: 69.87%+0.13% QoQ
FII holding: 4.17%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Management Change 13 Debt & Borrowing 9 Regulatory Approval 8 Merger & Restructuring 8 Earnings Call 5 Business Update 5 Other Announcement 3 Financial Results 3 Results Update 2 Credit Rating 2 Board Meeting Date 2 Annual General Meeting 2 Legal & Regulatory 1 Dividend 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

24 Jul 2026 17:58 IST BSE

Board Meeting Date

Alembic Pharmaceuticals Board Meeting Date

Alembic Pharmaceuticals has scheduled a board meeting on August 4, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.

Read the filing ↗

27 Apr 2026 13:20 IST BSE

Board Meeting Date

Alembic Pharmaceuticals Board Meeting Date

Alembic Pharmaceuticals Ltd has scheduled a Board Meeting on May 15, 2026. The board will consider and approve audited financial results for the quarter and year ended March 31, 2026, and recommend a dividend. The trading window remains closed until 48 hours after the results declaration.

Read the filing ↗